The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
Toher
C A
CA
Cardiovascular Division, University of Minnesota Medical School, Minneapolis 55455.
Francis
G S
GS
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D015996:Survival Rate
D000806:Angiotensin-Converting Enzyme Inhibitors